Publicaciones en las que colabora con Alfonso Jesús Domínguez-Gil Hurlé (15)

2014

  1. Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients

    Personalized Medicine, Vol. 11, Núm. 7, pp. 693-704

2009

  1. Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 7, pp. 2791-2798

  2. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokineticpharmacodynamic analysis

    Clinical Pharmacokinetics, Vol. 48, Núm. 4, pp. 273-280

2005

  1. Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 12, pp. 4934-4941

2004

  1. Iniciación de un programa de monitorización de lamotrigina en pacientes epilépticos

    Atencion Farmaceutica, Vol. 6, Núm. 2, pp. 97-101

1999

  1. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

    Biopharmaceutics and Drug Disposition, Vol. 20, Núm. 5, pp. 233-240

  2. Valproate population pharmacokinetics in children

    Journal of Clinical Pharmacy and Therapeutics, Vol. 24, Núm. 1, pp. 73-80

1997

  1. Carbamazepine population pharmacokinetics in children: Mixed-effect models

    Therapeutic Drug Monitoring, Vol. 19, Núm. 2, pp. 132-139

  2. Population pharmacokinetics of caffeine in premature neonates

    European Journal of Clinical Pharmacology, Vol. 52, Núm. 3, pp. 211-217

1996

  1. Application of population pharmacokinetics to the optimization of theophylline therapy

    Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 2, pp. 113-125

  2. FARMACOCINETICA CLINICA DE LOS INHIBIDORES SELECTIVOS DE LA RECAPTACION DE SEROTONINA

    Farmacia Hospitalaria, Vol. 20, Núm. 2, pp. 73-85

  3. Interaccion de diltiazem con farmacos antiepilepticos

    Farmacia Hospitalaria

1991

  1. Effect of dose on the kinetic behaviour of valproic acid: modifications in plasma protein binding.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 239-242

1989

  1. Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 1, pp. 19-22

1983

  1. Determination of N-oxide of picobenzide by differential pulse polarography

    Farmaco, Edizione Pratica, Vol. 38, Núm. 10, pp. 376-382